Aspire Private Capital LLC Makes New $1.53 Million Investment in STERIS plc $STE

Aspire Private Capital LLC bought a new position in shares of STERIS plc (NYSE:STE) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 6,035 shares of the medical equipment provider’s stock, valued at approximately $1,530,000.

A number of other large investors have also made changes to their positions in the stock. Steigerwald Gordon & Koch Inc. purchased a new stake in shares of STERIS in the third quarter valued at about $25,000. Board of the Pension Protection Fund purchased a new position in STERIS during the fourth quarter worth about $25,000. Harbor Investment Advisory LLC boosted its holdings in STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 60 shares during the last quarter. Cloud Capital Management LLC purchased a new stake in shares of STERIS in the 3rd quarter valued at approximately $29,000. Finally, Geneos Wealth Management Inc. grew its stake in shares of STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares during the period. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on STE. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, STERIS presently has an average rating of “Moderate Buy” and an average price target of $275.20.

STERIS Stock Down 0.5%

STERIS stock opened at $220.01 on Thursday. The company has a market capitalization of $21.58 billion, a PE ratio of 30.68 and a beta of 1.07. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. STERIS plc has a fifty-two week low of $204.90 and a fifty-two week high of $269.44. The firm has a 50 day moving average price of $240.19 and a 200 day moving average price of $248.16.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 EPS for the quarter, hitting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same quarter last year, the company earned $2.32 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Research analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th were given a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Tuesday, February 17th. STERIS’s dividend payout ratio is currently 35.15%.

Insider Activity at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the transaction, the director owned 705 shares in the company, valued at approximately $167,233.05. The trade was a 81.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.07% of the company’s stock.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.